Porokeratosis and immunosuppression

European Journal of Dermatology

Volumn 8, Issue 7, 1998, Pages 459-465

  Kanitakis, Jean ^a   Euvrard, Sylvie ^a   Faure, Michel ^a   Claudy, Alain ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; FLUOROURACIL; KERATOLYTIC AGENT; LUBRICATING AGENT; RETINOIC ACID; STEROID;

ACTINIC POROKERATOSIS; CHRONIC DISEASE; DARIER DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MALIGNANT TRANSFORMATION; ORGAN TRANSPLANTATION; PALLIATIVE THERAPY; PAPULE; PATHOGENESIS; POROKERATOSIS; POROKERATOSIS MIBELLI; REVIEW; SEX DIFFERENCE; SKIN INJURY; TOPICAL DRUG ADMINISTRATION;

FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; ORGAN TRANSPLANTATION; POROKERATOSIS; PROGNOSIS; RISK ASSESSMENT; TRANSPLANTATION IMMUNOLOGY;

EID: 0031688903     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Mibelli V. Contributo allo studio della ipercheratosi dei canali sudoriferi. Gior Ital Mal Ven 1893; 28: 313-55.
2. Kanitakis C, Ktenides M, Tsoitis G. Porokératose de Mibelli des lèvres bilatérale et symétrique. Dermatologica 1981; 163: 1-4.
3. Mehregan A, Khalili H, Fazel Z. Mibelli's porokeratosis of the face. A report of seven cases. J Am Acad Dermatol 1980; 3: 394-6.
4. Mikhail G, Wertheimer F. Clinical variants of porokeratosis (Mibelli). Arch Dermatol 1968; 98: 124-31.
5. Bogaert M, Hogan D. Linear porokeratosis in a 74-year-old woman. J Am Acad Dermatol 1991; 25: 338.
6. Chernosky M, Freeman R. Disseminated superficial actinic porokeratosis (DSAP): clinical studies and experimental production of lesions. Arch Dermatol 1967; 96: 611-24.
7. Chernosky M, Anderson D. Disseminated superficial actinic porokeratosis. Clinical studies and experimental production of lesions. Arch Dermatol 1969; 99: 401-7.
8. Cockerell C. Induction of disseminated superficial actinic porokeratosis by phototherapy for psoriasis. J Am Acad Dermatol 1991; 24: 301-2.
9. Neumann R, Knobler R, Metze D, Jurecka W, Gebhart W. Disseminated superficial actinic porokeratosis: experimental induction and exacerbation of skin lesions. J Am Acad Dermatol 1989; 21: 1182-8.
10. Hill MP, Balme B, Gho A, Perrot H. Porokératose disséminée superficielle avec amylose dermique. Ann Dermatol Vénéréol 1992; 119: 651-4.
11. Guss S, Osbourn R, Lutzner M. Porokeratosis palmaris, plantaris et disseminata: a third type of porokeratosis. Arch Dermatol 1971; 104: 366-73.
12. Patrizi A, Passarini B, Minghetti G, Massina M. Porokeratosis palmaris, plantaris et disseminata: an unusual clinical presentation. J Am Acad Dermatol 1989; 21: 415-8.
13. Lestringant G, Berge T. Porokeratosis punctata palmaris et plantaris. A new entity? Arch Dermatol 1989; 125: 816-9.
14. Helfman R, Poulos E. Reticulated porokeratosis: a unique variant of porokeratosis. Arch Dermatol 1985; 121: 1542-3.
15. Kanzaki T, Miwa N, Kobayashi T, Ogawa S. Eruptive pruritic papular porokeratosis. J Dermatol 1992; 19: 109-12.
16. Reed R, Leone P. Porokeratosis - a mutant clonal keratosis of the epidermis. Arch Dermatol 1970; 101: 340-7.
17. Otsuka F, Shima A, Ishibashi Y. Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis. Cancer 1989; 63: 891-6.
18. Otsuka F, Iwata M, Watanabe R, Chi H, Ishibashi Y. Porokeratosis: clinical and cellular characterization of its cancer-prone nature. J Dermatol 1992; 19: 702-6.
19. Magee J, McCalmont T, LeBoit P. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol 1994; 130: 187-90.
20. Kanitakis J, Misery L, Nicolas JF, Lyonnet S, Chouvet B, Haftek M, Faure M, Cloudy A, Thivolet J. Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol 1994; 131: 284-9.
21. Gray M, Smaller B, McNutt N. Carcinogenesis in porokeratosis: evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol 1991; 13: 438-44.
22. Anderson D, Chernosky M. Disseminated superficial actinic porokeratosis. Genetic aspects. Arch Dermatol 1969; 99: 408-12.
23. Commens C, Schumack S. Linear porokeratosis in two families with disseminated superficial actinic porokeratosis. Ped Dermatol 1987; 4: 209-14.
24. Sacppaticci S, Limbiase S, Orecchia G, Fraccaro M. Clonal chromosome abnormalities with preferential involvement of chromosome 3 in patients with porokeratosis of Mibelli. Cancer Genet Cytogenet 1989; 43: 89-94.
25. Watanabe R, Ishibashi Y, Otsuka F. Chromosomal instability and cellular hypersensitivity to X-ray irradiation of cultured fibroblasts derived from patients with porokeratotic patients' skin. Mutat Res 1990; 230: 273-8.
26. Schwartz T, Seiser A, Gschnait F. Disseminated superficial "actinic" porokeratosis. J Am Acad Dermatol 1984; 11: 724-30.
27. Shumack S, Commens C. Disseminated superficial actinic porokeratosis: a clinical study. J Am Acad Dermatol 1989; 20: 1015-22.
28. Halper S, Medinica M. Porokeratosis in a patient treated with total electron beam radiation. J Am Acad Dermatol 1990; 23: 754-5.
29. Nova M, Goldberg L, Mattison T, Halperin A. Porokeratosis arising in a burn scar. J Am Acad Dermatol 1991; 25: 354-6.
30. Nakazawa A, Matsuo I, Ohkido M. Porokeratosis localized to the access region for hemodialysis. J Am Acad Dermatol 1991; 21: 338-40.
31. Macmillan A, Roberts S. Porokeratosis of Mibelli after renal transplantation. Br J Dermatol 1974; 90: 45-51.
32. Bencini PL, Crosti C, Sala F. Porokeratosis: immunosuppression and exposure to sunlight. Br J Dermatol 1987; 116: 113-6.
33. Bencini PL, Tarantino A, Grimait R, Ponticelli C, Caputo R. Porokeratosis and immunosuppression. Br J Dermatol 1995; 132: 74-8.
34. Bouman T, van de Kerkhof P, Happle R. Disseminierte Porokeratosis nach Nierentransplantation. In: Gollnick H, Stadler R, eds. Dia-Klinik Fallvorstellungen anlässlich des 17. Weltkongresses fur Dermatologie. Stuttgart: Schattauer, 1987: 49-50.
35. Dodd H, Sarkany I. Porokeratosis of Mibelli following renal transplantation. Br J Dermatol 1988; 119 (suppl. 33): 101-2.
36. Euvrard S, Kanitakis J, D'Incan M, Lefrançois N, Mornex JF, Pouteil-Noble C, Faure M, Cloudy A. Porokératoses et greffe d'organe. Nouv Dermatol 1996; 15: 208.
37. Raychaudhuri S, Smoller B. Porokeratosis in immunosuppressed and non-immunosuppressed patients. Int J Dermatol 1992; 31: 781-2.
38. Chun SI, Lee JS, Kim NS, Park KD. Disseminated epidermolytic acanthoma with disseminated superficial porokeratosis and verruca vulgaris in an immunosuppressed patient. J Dermatol 1995; 22: 690-2.
39. Herranz P, Pizarro A, De Lucas R, Robayana M, Rubio F, Sanz A, Contreras F, Casado M. High incidence of porokeratosis in renal transplant patients. Br J Dermatol 1997; 136: 176-9.
40. Komorowski RA, Clowry L. Porokeratosis of Mibelli in transplant recipients. Am J Clin Pathol 1989; 91: 71-4.
41. Matsushita S, Kanekura T, Kanzaki T. A case of disseminated superficial actinic porokeratosis subsequent to renal transplantation. J Dermatol 1997; 24: 110-2.
42. Wilkinson S, Cartwright P, English J. Porokeratosis of Mibelli and immunosuppression. Clin Exp Dermatol 1991; 16: 61-2.
43. Sudoh H, Yokote R, Takigawa M, Iwatsuki K. A case of porokeratosis of Mibelli after renal transplantation. Hifu Rinsyou 1993; 35: 50-1.
44. Manganoni A, Faccheti F, Gavazzoni R. Involvement of epidermal Langerhans cells in porokeratosis of immunosuppressed renal transplant patients. J Am Acad Dermatol 1989; 21: 799-801.
45. e Symposium "Peau et Greffes d'Organe", Lyon, 23 octobre 1998.
46. Auslaender S, Barzilay A, Trau H. Porokeratosis of the skin in an immunosuppressed patient. Harefuah 1994; 127: 303-5.
47. Rothman I, Wirth P, Klaus M. Porokeratosis of Mibelli following heart transplant. Int J Dermatol 1992; 31: 52-4.
48. O'Connell B, Abel E, Nickoloff B, Bell B, Hunt S, Theodore J. Dermatologic complications following heart transplantation. J Heart Transplant 1986; 5: 430-6.
49. Ghigliotti G, Nigro A, Gambini C, Farris A, Burroni A, De Marchi R. Porokératose de Mibelli après une greffe de moelle. Ann Dermatol Vénéréol 1992; 119: 968-70.
50. Lederman J, Sober A, Lederman G. Immunosuppression: a cause of porokeratosis? J Am Acad Dermatol 1985; 13: 75-9.
51. Gilead L, Guberman D, Zlotogorski A, Vardy D, Klaus S. Immunosuppression-induced porokeratosis of Mibelli: complete regression of lesions upon cessation of immunosuppressive therapy. J Eur Acad Dermatol Venereol 1995; 5: 170-2.
52. Rio B, Magana C, Le Tourneau A, Bachmeyer C, Levy V, Hamont N, Diebold J, Zittoun R. Disseminated superficial porokeratosis after autologous bone marrow transplantation. Bone Marow Transplant 1997; 19: 77-9.
53. Nicolas JF, Fauvet N, Kanitakis J, Hermier C, Thivolet J. Porokératose "actinique" superficielle disséminée et immunosuppression: à propos de deux cas. Nouv Dermatol 1990; 9: 187-8.
54. Fields L, White C, Maziarz R. Rapid development of disseminated superficial porokeratosis after transplant induction therapy. Bone Marrow Transplant 1995; 15: 993-5.
55. Vire G, Latour D, King L. Porokeratosis and immunosuppression. J Am Acad Dermatol 1986; 14: 683.
56. Zenarola P, Melillo L, Lomuto M, Carotenuto M, Enzo Gomes V, Marzocchi W. Exacerbation of porokeratosis: a sign of immunodepression J Am Acad Dermatol 1993; 29: 1035-6.
57. Luelmo-Aguilar J, Gonzalez-Castro U, Mieras-Barcelo C, Castells-Rodellas A. Disseminated porokeratosis and myelodysplastic syndrome. Dermatology 1992; 184: 289.
58. Puissant A, Venencie JY. In: Lederman J, Sober A, Lederman G. Porokeratosis and immunosuppression (letter). J Am Acad Dermatol 1986; 14: 683-4.
59. Rodriguez E, Jakubowicz S, Chinchilla D, Carril A, Viglioglia P. Porokeratosis of Mibelli and HIV infection. Int J Dermatol 1996; 35: 402-4.
60. Velez A, Del Rio A, Fuente C, Belinchon I, Martin N, Sanchez Yus E. Disseminated superficial actinic porokeratosis and immunosuppression. Eur J Dermatol 1992; 2: 336-8.
61. Morton C, Shuttleworth D, Douglas WS. Porokeratosis and Crohn's disease. J Am Acad Dermatol 1995; 32: 894-7.
62. Feverman E, Sandbank M. Disseminated superficial porokeratosis in a patient with pemphigus vulgaris treated with steroids. Acta Derm Venereol (Stockh) 1974; 48: 59-61.
63. Neumann R, Knobler R, Metze D, Jurecka W. Disseminated superficial porokeratosis and immunosuppression. Br J Dermatol 1988; 119: 375-80.
64. Leibovici V, Zeidenbaum M, Goldenhersch M. Porokeratosis and immunosuppressive treatment for pemphigus foliaceus. J Am Acad Dermatol 1988; 19: 910-1.
65. Tsambaos D, Spiliopoulos T. Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression. J Am Acad Dermatol 1993; 28: 651-2.
66. Tatnall F, Sarkany I. Porokeratosis of Mibelli in an immunosuppressed patient. Br J Dermatol 1988; 119 (suppl. 33): 100-1.
67. Park BS, Moon SE, Kim JA. Disseminated superficial porokeratosis in a patient with chronic liver disease. J Dermatol 1997; 24: 485-7.
68. Hunt S, Sharra W, Abell E. Linear and punctate porokeratosis associated with end-stage liver disease. J Am Acad Dermatol 1991; 25: 937-9.
69. Dippel E Haas N, Czarnetzki B. Porokeratosis of Mibelli associated with active chronic hepatitis and vitiligo. Acta Derm Venereol (Stockh) 1994; 74: 463-4.
70. Klapholtz L, Goldenhersh M, Sherman Y, Leibivici V. Superficial actinic porokeratosis and cystic fibrosis. Acta Derm Venereol (Stockh) 1991; 71: 440-1.
71. Grattan C, Christopher A. Porokeratosis and immunosuppression (letter). J Royal Soc Med 1987; 80: 597-8.
72. Jurecka W, Neumann R, Knobler R. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol 1991; 24: 96-101.
73. Shumack S, Commens C, Kossard S. Disseminated superficial actinic porokeratosis. A histological review of 61 cases with particular reference to lymphocytic infiltration. Am J Dermatopathol 1991; 23: 26-31.
74. Wade T, Ackerman B. Cornoid lamellation: a histologic reaction pattern. Am J Dermatopathol 1980; 2: 5-15.
75. Ito M, Fujiwara H, Maruyama T, Oguro K, Ishihara O, Sato Y. Morphogenesis of the comoid lamella: histochemical, immunohistochemical and ultrastructural study of porokeratosis. J Cutan Pathol 1991; 18: 247-56.
76. Sato A, Anton-Lamprecht I, Schnyder U. Ultrastructure of inborn errors of keratinization: porokeratosis Mibelli and disseminated superficial actinic porokeratosis. Arch Dermatol Res 1976; 255: 271-84.
77. Tanaka M, Terui T, Kudo K, Tagami H. Inflammatory disseminated superficial porokeratosis followed by regression. Br J Dermatol 1995; 132: 153-5.
78. Otsuka F, Huang J, Sawara K, Asahina A, Ishibashi Y. Disseminated porokeratosis accompanying multicentric Bowen's disease. Characterization of porokeratotic lesions progressing to Bowen's disease. J Am Acad Dermatol 1990; 23: 355-9.
79. Otsuka F, Someya T, Ishibashi Y. Porokeratosis and malignant skin tumors. J Cancer Res Clin Oncol 1991; 117: 55-60.
80. Sasson M, Krain A. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996; 22: 339-42.
81. Brodkin R, Rickert R, Fuller W, Saporito C. Malignant disseminated porokeratosis. Arch Dermatol 1987; 123: 1521-6.
82. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli. Overview and review of the literature. Acta Derm Venereol (Stockh) 1997; 77: 207-13.
83. Harrison P, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol 1994; 19: 95.
84. Hacham-Zadeh S, Holubar K. Etretinate in the treatment of disseminated porokeratosis of Mibelli. Int J Dermatol 1985; 24: 258-60.
85. Danno K, Yamamoto M, Yokoo T. Etretinate treatment in disseminated porokeratosis. J Dermatol 1988; 15: 440-4.
86. Knobler R, Neumann R. Exacerbation of porokeratosis during etretinate therapy. Acta Derm Venereol (Stockh) 1990; 70: 319-22.
87. Cohen E, Komorowski R, Clowry L. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987; 88: 32-7.
88. Ponticelli C, Bencini P. Disseminated porokeratosis in immunosuppressed patients. Nephrol Dial Transplant 1996; 11: 2353-4.